Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
Use this VYGR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VYGR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VYGR SEC filings page. Lician reads the product cache first so this HTML stays unique to Voyager Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VYGR income, balance, and cash tables.